Several studies have suggested possible roles of GSK-3β as a tumor suppressor gene in HCC, whereas, other studies have indicated that GSK-3β is a potential therapeutic target for this cancer. This evidence concerns the gene ENSG00000279284 and hepatocellular carcinoma.